Collectively, these results showed that RNase1 contributed to a significant induction of CD4+ Th1, CD4+ Th17, and NK cells, which associate with antitumor immunity, as well as a reduction of immunosuppressive MDSCs that associate with pro-tumor activity. Here, RNASE1 is linked to neoplasm.